ONCY is trading 5.2% down today at $0.83 as the stock continues to face pressure from negative technical indicators and broader market trends.
- Recent analysis has labeled the stock a strong sell on technicals, highlighting ongoing clinical and financial risks.
- With no fresh company-specific catalysts reported today, the move appears driven by risk-off trading in smaller biotech stocks and overall market weakness.